Every study, decoded.

Longevity

Why Everyone in Longevity Is Suddenly Stacking NAD+ With Peptides

NAD+ levels drop 50% by age 60. Longevity docs are restoring them with NMN and stacking targeted peptides in phased protocols, here's the science behind what actually works.

3 May 2026

GLP-1

Tirzepatide vs. Semaglutide: The Head-to-Head Trial Results Are In

The SURMOUNT-5 trial compared tirzepatide and semaglutide head-to-head in 751 people. Tirzepatide delivered 47% more weight loss. Here's what the data shows.

3 May 2026

GLP-1

Retatrutide vs Tirzepatide vs Semaglutide: The Weight Loss Numbers Nobody Expected

Retatrutide hits 22-24% weight loss, tirzepatide reaches 18-22%, and semaglutide caps at 14-20%. A 2026 meta-analysis of 26 trials shows triple agonists beat dual agonists, which beat single GLP-1 drugs.

3 May 2026

GLP-1

Tirzepatide vs Semaglutide: More Weight Loss Doesn't Mean Better Outcomes

Tirzepatide causes more weight loss than semaglutide, but real-world data shows semaglutide reduces heart attack and stroke risk by 29%, independent of weight loss. Here's what that means.

3 May 2026

Peptides

The Peptide That Actually Reverses Skin Aging (And The Science Behind It)

GHK-Cu is the only skin peptide with clinical data proving it rebuilds collagen and reduces wrinkles. Here's what 40 years of research actually shows.

3 May 2026

Longevity

GLP-1 Drugs Aren't Just For Weight Loss Anymore, They're Becoming Longevity Medicine

GLP-1 drugs reduce cardiac events and protect kidneys even without major weight loss. Researchers are reconsidering them as longevity medicine.

3 May 2026

GLP-1

The GLP-1 Showdown: Which Drug Actually Protects Your Heart Better?

New 2025-2026 studies reveal tirzepatide and semaglutide protect your heart differently depending on whether you have diabetes, fatty liver, or existing heart disease, here's which one wins in each scenario.

3 May 2026

GLP-1

Retatrutide Just Posted 28.7% Weight Loss, Here’s What That Actually Means

Retatrutide’s TRIUMPH-4 readout paired 28.7% weight loss with a 75.8% drop in knee pain over 68 weeks. Here’s why the triple agonist signal matters for people stuck between obesity and osteoarthritis.

3 May 2026

GLP-1

Amycretin Is Basically CagriSema in One Molecule, Here’s Why the Phase 2 Diabetes Data Matters

Weekly amycretin shots dropped HbA1c by 1.8 points and weight by 14.5% while the oral pill still managed 10.1% weight loss in 36 weeks. Novo just moved it into Phase 3 diabetes trials for a reason.

3 May 2026

Longevity

FOXO4-DRI Hasn’t Hit Human Trials Yet, Here’s Why Longevity People Still Talk About It

FOXO4-DRI is still stuck in animal studies, but 2026 vascular-aging data and fresh senolytic trials explain why it keeps trending. Here’s the realistic state of play.

3 May 2026

Peptides

The Semaglutide + Bimagrumab Stack That Keeps Your Muscle While Dropping 22% Body Weight

The BELIEVE phase 2b trial just showed that pairing semaglutide with bimagrumab delivers 22% weight loss with 92.8% of it coming from fat, proving you can cut pounds without sacrificing muscle.

3 May 2026

GLP-1

Orforglipron Is the Oral GLP-1 Contender Everyone With Needle Fatigue Has Been Waiting For

ACHIEVE and ATTAIN data show orforglipron dropping HbA1c by up to 2.1 points and delivering double-digit weight loss without injections, putting a true anytime oral GLP-1 on the runway for 2025–2026 approvals.

3 May 2026

Peptides

The FDA Just Reclassified BPC-157. Here's What Actually Happened.

The FDA reclassified BPC-157 in February 2026. Here's what the science actually shows, and what you need to know before considering this controversial peptide.

3 May 2026

Longevity

Why NAD+ Testing is Trending in 2026 (And Why Injectable NR Might Be the Next Move)

NAD+ drops 50% by age 50. Injectable NR and NMNH are changing the game. Here's why oral supplements often fail, and what the 2026 research shows.

3 May 2026

GLP-1

Tirzepatide Is Now Being Tested for Type 1 Diabetes and Alcohol Use Disorder. Here's Why That's Wild.

Tirzepatide isn't just for weight loss anymore. 2026 trials are testing it for type 1 diabetes and alcohol use disorder, here's what the science shows.

3 May 2026

Peptides

The Peptides That Actually Reverse Skin Aging (According to the Data)

GHK-Cu, Matrixyl, and Argireline have clinical data showing they improve skin thickness, elasticity, and wrinkle depth. Here's what 18 months of research and testing taught me about peptides for skin.

3 May 2026

GLP-1

The GLP-1 Side Effect Nobody's Tracking (But 2026 Research Says You Should)

New 2026 research shows GLP-1 users have 29% higher osteoporosis risk over five years. Here's what's happening to your bones, and what you should do about it.

3 May 2026

Peptides

The Triple Peptide Stack: TB-500, BPC-157, and GHK-Cu Combined

12 March 2026

Peptides

Growth Hormone Secretagogues: What They Are and Who Uses Them

Growth hormone secretagogues like Ipamorelin and CJC-1295 tell your body to release more natural growth hormone for fat loss, muscle retention, better sleep, and anti-aging. This guide explains how they work and what to expect.

10 March 2026

GLP-1

GLP-1s Explained: Why 1 in 7 Americans Are Taking Them

GLP-1 agonists like semaglutide and tirzepatide are the most effective weight-loss drugs ever created. This guide explains how they work, what to expect, side effects, and who should use them.

10 March 2026

Peptides

The 4 Main Peptide Categories (And What Each One Does)

Most peptides fall into 4 categories: healing/recovery, growth hormone, metabolism/weight loss, and longevity/cognitive. This guide explains each category and helps you choose the right peptide for your goals.

10 March 2026

Peptides

Where Do You Actually Get Peptides? (The Sourcing Spectrum Explained)

Peptide sourcing ranges from pharmaceutical-grade to gray-market research chemicals. This guide explains all three tiers, quality standards, risks, and how to choose safely.

10 March 2026

Peptides

How Peptides Actually Work (Without the Science Jargon)

Peptides use a lock-and-key system to deliver precise instructions to your cells. This article explains how receptor binding and cell signaling work, in plain language anyone can understand.

10 March 2026

Peptides

What Are Peptides? (And Why Everyone's Talking About Them in 2026)

Peptides are short chains of amino acids that send specific instructions to your cells. This beginner-friendly guide explains what they are, how they work, and why 2026 is the year they went mainstream.

10 March 2026